Literature DB >> 35607485

Early Transcatheter Heart Valve Pannus Leading to Coronary Obstruction Managed With Orthotopic Chimney Stenting.

Mariama Akodad1, Anthony Chuang1, Abdul Ihdayhid1, Andrew G Chatfield1, Jonathon Leipsic1, Anson Cheung1, David A Wood1, Anthony Della Siega2, M Bilal Iqbal2, John G Webb1, Janarthanan Sathananthan1.   

Abstract

Entities:  

Year:  2022        PMID: 35607485      PMCID: PMC9123377          DOI: 10.1016/j.cjco.2022.01.008

Source DB:  PubMed          Journal:  CJC Open        ISSN: 2589-790X


× No keyword cloud information.
A 78-year-old woman was admitted with acute coronary syndrome 6 months after transcatheter aortic valve replacement (TAVR) with a 26-mm Evolut R transcatheter heart valve (THV; Medtronic, Minneapolis, MN). Coronary angiography was challenging, and only nonselective images were obtained. She was treated with dual antiplatelet therapy and therapeutic anticoagulation. However, despite aggressive antithrombotic management for 1 week, she continued to deteriorate and was eventually referred to our centre with refractory angina and rising troponin up to 2432 ng/L (normal: < 14 ng/L). An urgent cardiac computed tomography (CT) scan showed extensive pannus on the THV frame, expanding up to the level of the coronary arteries and the THV commissure posts positioned in front of both coronary artery ostia (Fig. 1, A and B). Thrombus was also highlighted in the sinuses of Valsalva, as a consequence of impaired flow caused by the tissue ingrowth. The patient was deemed to be at prohibitive risk for surgery, due to a porcelain aorta. Considering the critical presentation, with worsening symptoms and dynamic electrocardiogram changes in the anterior leads, she was referred for percutaneous coronary intervention to improve left main perfusion.
Figure 1

(A, B) Thrombus and pannus formation on the Evolut R transcatheter heart valve (Medtronic, Minneapolis, MN). (C) The transcatheter heart valve neo-commissure in front of the coronary ostia (white arrows).

(A, B) Thrombus and pannus formation on the Evolut R transcatheter heart valve (Medtronic, Minneapolis, MN). (C) The transcatheter heart valve neo-commissure in front of the coronary ostia (white arrows). A 6 Fr Judkins Left (Cordis, FL) 3.0 guiding catheter was unable to cross the THV struts, with widespread ST depression on the electrocardiogram, while the guiding catheter was interacting with the THV frame (Fig. 2A). After wiring the left anterior descending artery, a Guideliner (Vascular Solutions, Morrisville, NC) was advanced over a 2.5 x 12-mm balloon (Fig. 2B; Video 1 , view video online). A first 3.5 x 28-mm drug-eluting stent was implanted from the left anterior descending artery back across the THV strut (Fig. 2C; Video 2 , view video online). Despite stent reinflation at high pressure, a significant waist at the level of the THV strut was noted, and the decision was made to implant a second overlapping stent to improve radial strength at this level. Intravascular imaging was not performed, as the stent under expansion was visible angiographically, and to avoid any potential for stent distortion. A second overlapping 4 x 12-mm stent then was inserted from the left main carina back into the THV frame, to improve radial strength, and post-dilated with a 4.5-mm noncompliant balloon with an excellent angiographic result and immediate resolution of chest pain and ST depression (Fig. 2D; Videos 3 and 4, , view videos online). Given the complete resolution of symptoms and right coronary artery small diameter, this was managed medically. The patient was discharged under oral anticoagulation (rivaroxaban) and clopidogrel. Follow-up with alternated CT scan and stress test was recommended. At 6-month follow-up, the patient was asymptomatic, and a CT scan confirmed stent patency.
Figure 2

(A) Electrocardiogram changes during catheter interaction with the Evolut R transcatheter heart valve (Medtronic, Minneapolis, MN). (B) Guideliner (Vascular Solutions, Morrisville, NC) advanced into left main artery over coronary balloon. (C) Implantation of first stent. (D) Final angiographic result.

(A) Electrocardiogram changes during catheter interaction with the Evolut R transcatheter heart valve (Medtronic, Minneapolis, MN). (B) Guideliner (Vascular Solutions, Morrisville, NC) advanced into left main artery over coronary balloon. (C) Implantation of first stent. (D) Final angiographic result. Coronary access may be challenging after TAVR, with 16% of commissural misalignment reported with the Evolut R THV., Commissural alignment may be improved with the Evolut platform, according to recent recommendations, including the positioning of the flush port at the “3 o’clock” position and the use of the cusp-overlap view for THV positioning. The CT scan may be useful to define the mechanism of post-TAVR angina and to guide subsequent coronary intervention., The orthotopic chimney-stenting, allowing coronary stenting through the THV struts, has been described previously and may be facilitated using a shorter guiding catheter and a Guideliner., CT scanning is key to guiding coronary access and understanding the mechanism of acute coronary syndrome in patients with previous TAVR. Guideliner may be of help in facilitating coronary access and stent delivery through the THV struts. Orthotopic chimney stenting may be an acceptable alternative to surgery in cases with coronary access impairment and prohibitive surgical risk. A double layer of stent may improve radial strength at the THV strut level.
  5 in total

1.  An "orthotopic" snorkel-stenting technique to maintain coronary patency during transcatheter aortic valve replacement.

Authors:  Francesco Burzotta; Mila Kovacevic; Cristina Aurigemma; Osama Shoeib; Piergiorgio Bruno; Stefano Cangemi; Enrico Romagnoli; Carlo Trani
Journal:  Cardiovasc Revasc Med       Date:  2020-12-11

2.  Coronary Access After TAVR With a Self-Expanding Bioprosthesis: Insights From Computed Tomography.

Authors:  Mohammad Abdelghani; Martin Landt; Hussein Traboulsi; Björn Becker; Gert Richardt
Journal:  JACC Cardiovasc Interv       Date:  2020-03-23       Impact factor: 11.195

Review 3.  Coronary Angiography and Percutaneous Coronary Intervention After Transcatheter Aortic Valve Replacement.

Authors:  Matias B Yudi; Samin K Sharma; Gilbert H L Tang; Annapoorna Kini
Journal:  J Am Coll Cardiol       Date:  2018-03-27       Impact factor: 24.094

4.  Alignment of Transcatheter Aortic-Valve Neo-Commissures (ALIGN TAVR): Impact on Final Valve Orientation and Coronary Artery Overlap.

Authors:  Gilbert H L Tang; Syed Zaid; Andreas Fuchs; Tsuyoshi Yamabe; Farhang Yazdchi; Eisha Gupta; Hasan Ahmad; Klaus F Kofoed; Joshua B Goldberg; Cenap Undemir; Ryan K Kaple; Pinak B Shah; Tsuyoshi Kaneko; Steven L Lansman; Sahil Khera; Jason C Kovacic; George D Dangas; Stamatios Lerakis; Samin K Sharma; Annapoorna Kini; David H Adams; Omar K Khalique; Rebecca T Hahn; Lars Søndergaard; Isaac George; Susheel K Kodali; Ole De Backer; Martin B Leon; Vinayak N Bapat
Journal:  JACC Cardiovasc Interv       Date:  2020-03-16       Impact factor: 11.195

5.  Coronary Access After TAVR.

Authors:  Tomoki Ochiai; Tarun Chakravarty; Sung-Han Yoon; Danon Kaewkes; Nir Flint; Vivek Patel; Sahar Mahani; Ripandeep Tiwana; Navjot Sekhon; Mamoo Nakamura; Wen Cheng; Raj Makkar
Journal:  JACC Cardiovasc Interv       Date:  2020-03-23       Impact factor: 11.195

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.